|
|
|
|
|
The Niche
|
Stem Cell & Regenerative Med Newsletter
|
|
|
|
|
|
Weekly reads: artificial wombs, mice with rat brains, Neuralink
|
|
|
|
It feels like we are marching towards a future in which key aspects of human reproduction, including the use of artificial wombs, could be substantially different than for most of history. The FDA is considering allowing a clinical trial for use of artificial wombs in people. Human trials of artificial wombs could start soon. Here’s what you need to know, …
|
|
|
|
|
|
|
|
Burst Biologics unapproved biologic used by Weill Cornell: was there a cover-up?
|
|
|
|
The New York Times just broke a story on Burst Biologics and Weill Cornell that fits with long-standing troubling questions about regenerative biologics producers. The story also bears on the doctors and hospitals like Weill Cornell that were or are customers of the suppliers. Further, what is the FDA's role in all of this? The piece is entitled: How Much Do …
|
|
|
|
|
|
|
|
Defining epigenetic reprogramming, cellular reprogramming & rejuvenation
|
|
|
|
Epigenetic reprogramming is a term used in cell biology that is increasingly ending up in news stories too. Unfortunately, some folks, especially in the cellular rejuvenation and anti-aging space, are getting this term and other things confused. Just to start off, epigenetic reprogramming does not specifically mean cellular rejuvenation. The goal of today's post is to clearly define epigenetic reprogramming. …
|
|
|
|
|
|
